Latest Dynavax Technologies Corporation Stories
Findings Could Lead to Lower Doses of Medication for Lupus Patients, Reducing Serious Side Effects DALLAS, July 12 /PRNewswire-USNewswire/ -- Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today.
Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that it will present at the Credit Suisse 2008 Healthcare Conference on Wednesday, November 12, 2008 at 3:00 p.m. MST (2:00 p.m. PST) in Phoenix, Arizona.
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.